Loading…
4CPS-136 Standard first day of life central parenteral nutrition, experience in real clinical practice
Background and ImportanceStandard parenteral nutrition (PN) solutions should generally be used over individualised PN solutions in the majority of paediatric and newborn patients, including very-low-birth-weight premature infants,1 starting as soon as possible and within 8h at the latest.2 In 2021 o...
Saved in:
Published in: | European journal of hospital pharmacy. Science and practice 2023-03, Vol.30 (Suppl 1), p.A67-A67 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background and ImportanceStandard parenteral nutrition (PN) solutions should generally be used over individualised PN solutions in the majority of paediatric and newborn patients, including very-low-birth-weight premature infants,1 starting as soon as possible and within 8h at the latest.2 In 2021 our Paediatric and Pharmacy Departments designed a standard central PN (CPN) to have ready to use, in order to meet the nutritional needs of most newborn patients in their first day of life.Aim and ObjectivesEvaluate the use of the standard first day of life CPN and describe clinical data of patients and the time frame for its start.Material and MethodsObservational, retrospective and longitudinal study conducted between March 2022 and September 2022 in a tertiary hospital. A database was designed to record all prepared CPN, their use and data of patients who received them.Results55 CPN were prepared and 32 (58.2%) were administered. 31 newborn required PN and 100% received the standard first day of life CPN, 18 (58.1%) patients were female, the mean gestational age was 28.5 weeks, the mean weight was 1138.2g and 12 (38.7%) were multiple pregnancies. The indication of PN was: 23 (74.2%) preterm infants born |
---|---|
ISSN: | 2047-9956 2047-9964 |
DOI: | 10.1136/ejhpharm-2023-eahp.141 |